Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Nephron
|
April 22, 2015
Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease
Eiji Higashihara, Kikuo Nutahara, Takatsugu Okegawa, et al.
Disease Models & Mechanisms
|
September 30, 2024
Preclinical evaluation of targeted therapies for central nervous system metastases
Alexander J Pfeil, Joshua D Hale, Tiger S Zhang, et al.
Clinical and Experimental Nephrology
|
August 12, 2018
Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases
Eiji Higashihara, Kouji Yamamoto, Shinya Kaname, et al.
Scientific Reports
|
May 31, 2023
Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
Toshihiro Shibutani, Risa Goto, Isao Miyazaki, et al.
Kidney International Reports
|
September 21, 2020
Estimation of Changes in Kidney Volume Growth Rate in ADPKD
Eiji Higashihara, Hiroshi Fukuhara, John Ouyang, et al.
Antiviral Research
|
November 4, 2019
Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase
Fumihiro Kato, Yasunori Nio, Kazumi Yagasaki, et al.
Clinical and Experimental Nephrology
|
October 7, 2017
A potentially crucial role of the PKD1 C-terminal tail in renal prognosis
Eiji Higashihara, Shigeo Horie, Moritoshi Kinoshita, et al.
Nature Cancer
|
September 24, 2023
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
Isao Miyazaki, Igor Odintsov, Keiji Ishida, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Nephron
|
April 22, 2015
Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease
Eiji Higashihara, Kikuo Nutahara, Takatsugu Okegawa, et al.
Disease Models & Mechanisms
|
September 30, 2024
Preclinical evaluation of targeted therapies for central nervous system metastases
Alexander J Pfeil, Joshua D Hale, Tiger S Zhang, et al.
Clinical and Experimental Nephrology
|
August 12, 2018
Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases
Eiji Higashihara, Kouji Yamamoto, Shinya Kaname, et al.
Scientific Reports
|
May 31, 2023
Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
Toshihiro Shibutani, Risa Goto, Isao Miyazaki, et al.
Kidney International Reports
|
September 21, 2020
Estimation of Changes in Kidney Volume Growth Rate in ADPKD
Eiji Higashihara, Hiroshi Fukuhara, John Ouyang, et al.
Antiviral Research
|
November 4, 2019
Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase
Fumihiro Kato, Yasunori Nio, Kazumi Yagasaki, et al.
Clinical and Experimental Nephrology
|
October 7, 2017
A potentially crucial role of the PKD1 C-terminal tail in renal prognosis
Eiji Higashihara, Shigeo Horie, Moritoshi Kinoshita, et al.
Nature Cancer
|
September 24, 2023
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations
Isao Miyazaki, Igor Odintsov, Keiji Ishida, et al.
Page
of 2